BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25189424)

  • 1. The immune response and antibacterial therapy.
    Anuforom O; Wallace GR; Piddock LV
    Med Microbiol Immunol; 2015 Apr; 204(2):151-9. PubMed ID: 25189424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is inadequate antibacterial therapy?
    Moellering RC
    Clin Infect Dis; 2009 Oct; 49(7):1006-8. PubMed ID: 19719418
    [No Abstract]   [Full Text] [Related]  

  • 4. Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?
    Labro MT
    Clin Microbiol Rev; 2000 Oct; 13(4):615-50. PubMed ID: 11023961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial stress response: understanding the molecular mechanics to identify possible therapeutic targets.
    Kumar A; Rahal A; Sohal JS; Gupta VK
    Expert Rev Anti Infect Ther; 2021 Feb; 19(2):121-127. PubMed ID: 32811215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SOME ASPECTS OF NON-SPECIFIC PROPHYLAXIS AND THERAPY OF ESPECIALLY DANGEROUS INFECTIONS].
    Filippenko AV; Omelchenko ND; Ivanova IA; Bespalova IA; Doroshenko EP; Galicheva AL
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):111-6. PubMed ID: 26829862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting virulence not viability in the search for future antibacterials.
    Heras B; Scanlon MJ; Martin JL
    Br J Clin Pharmacol; 2015 Feb; 79(2):208-15. PubMed ID: 24552512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic strategies in infection and cancer management.
    Clayton P
    Curr Aging Sci; 2012 Dec; 5(3):218-24. PubMed ID: 23387881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents.
    Labro MT
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):319-40. PubMed ID: 22397566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the role of the immune response in preventing antibiotic resistance.
    Handel A; Margolis E; Levin BR
    J Theor Biol; 2009 Feb; 256(4):655-62. PubMed ID: 19056402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting bacterial topoisomerases: how to counter mechanisms of resistance.
    Tse-Dinh YC
    Future Med Chem; 2016 Jun; 8(10):1085-100. PubMed ID: 27285067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review.
    Oliver SP; Murinda SE; Jayarao BM
    Foodborne Pathog Dis; 2011 Mar; 8(3):337-55. PubMed ID: 21133795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-bacterial monoclonal antibodies: back to the future?
    Oleksiewicz MB; Nagy G; Nagy E
    Arch Biochem Biophys; 2012 Oct; 526(2):124-31. PubMed ID: 22705202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial monoclonal antibodies: the next generation?
    DiGiandomenico A; Sellman BR
    Curr Opin Microbiol; 2015 Oct; 27():78-85. PubMed ID: 26302478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surviving innate immunity.
    Nizet V; Gallo RL
    Trends Microbiol; 2002 Aug; 10(8):358-9. PubMed ID: 12160630
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of antibacterial resistance.
    Hickey SM; Nelson JD
    Adv Pediatr; 1997; 44():1-41. PubMed ID: 9265966
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel Antibacterial Agents: An Emergent Need to Win the Battle Against Infections.
    Simões NG; Bettencourt AF; Monge N; Ribeiro IAC
    Mini Rev Med Chem; 2017; 17(14):1364-1376. PubMed ID: 27629996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogen modulating and immunomodulating aspects of antibiotic therapy].
    Hof H; Pulverer G
    Z Arztl Fortbild (Jena); 1992 Mar; 86(6):259. PubMed ID: 1590004
    [No Abstract]   [Full Text] [Related]  

  • 19. White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens.
    Infectious Diseases Society of America
    Clin Infect Dis; 2012 Oct; 55(8):1031-46. PubMed ID: 22891041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial resistance: is there a way out of the woods?
    Marra A
    Future Microbiol; 2011 Jul; 6(7):707-9. PubMed ID: 21797683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.